News

Sensory Stimulation Systems, and GENUS, refer to a noninvasive procedure, i.e., a "digital therapeutic," being developed by Cognito Therapeutics. The company developed a wearable GammaSense ...
Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies Características clínicas de pacientes com ataxia cerebelar associada a anticorpos anti-GAD ...
Each GNP patient presented sensory ataxia and preserved motor strength. PNP The diagnosis of PNP was defined by NCS and clinical presentation. The NCS required at least one abnormality (potential ...
If you’re the parent of a child with sensory sensitivities, you know that it can be challenging to find activities and attractions that both you and your little one can enjoy. I live near Philadelphia ...
The authors describe three siblings with ataxia with oculomotor apraxia type 1 born to consanguineous parents.
Biogen Launches Phase 3 Pediatric Trial Of Omaveloxolone For Friedreich Ataxia. Published on June 23, 2025 at 1:36 am by Fatima Gulzar in News ...
Sensory systems are composed of receptors that sense the sensory stimuli, brain areas involved in sensory perception and neural pathways that connect them.
A series of pavilions along an abandoned Parisian railway, designed to engage the senses, are among the architectural proposals from students at Architectural Institute Paris.
Omaveloxolone is currently marketed under the brand name SKYCLARYS® for the treatment of adults and adolescents aged 16 years and older affected by Friedreich ataxia CAMBRIDGE, MA, USA I June 18, 2025 ...
Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to <16 years old with Friedreich ataxia, a rare neurodegenerative disorder BRAVE study will explore the ...
Persistent sadness, fatigue, changes in sleep and appetite, or loss of interest are common symptoms in mothers suffering from perinatal depression.
Michael Gehr, of Edmond, and his family are on a mission to help find a cure for a rare genetic disease that he was diagnosed with at age 15.